These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 30864840)

  • 1. Chronic kidney disease and the gut microbiome.
    Hobby GP; Karaduta O; Dusio GF; Singh M; Zybailov BL; Arthur JM
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1211-F1217. PubMed ID: 30864840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of CKD on Uremic Toxins and Gut Microbiota.
    Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota issue in CKD: how promising are gut-targeted approaches?
    Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
    J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.
    Chaves LD; McSkimming DI; Bryniarski MA; Honan AM; Abyad S; Thomas SA; Wells S; Buck M; Sun Y; Genco RJ; Quigg RJ; Yacoub R
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F487-F502. PubMed ID: 29693447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
    Briskey D; Tucker P; Johnson DW; Coombes JS
    Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats.
    Sueyoshi M; Fukunaga M; Mei M; Nakajima A; Tanaka G; Murase T; Narita Y; Hirata S; Kadowaki D
    Clin Exp Nephrol; 2019 Jul; 23(7):908-919. PubMed ID: 30895529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease.
    Lau WL; Vaziri ND
    J Ren Nutr; 2017 Nov; 27(6):458-461. PubMed ID: 29056165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urea and impairment of the Gut-Kidney axis in Chronic Kidney Disease.
    Di Iorio BR; Marzocco S; Nardone L; Sirico M; De Simone E; Di Natale G; Di Micco L
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.
    Vaziri ND
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):587-92. PubMed ID: 23010760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
    Glorieux G; Gryp T; Perna A
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
    Yang CY; Tarng DC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
    Fryc J; Naumnik B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uremic toxins and gut micro biome].
    Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
    Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease.
    El Amouri A; Snauwaert E; Foulon A; Vande Moortel C; Van Dyck M; Van Hoeck K; Godefroid N; Glorieux G; Van Biesen W; Vande Walle J; Raes A; Eloot S
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats.
    Kieffer DA; Piccolo BD; Vaziri ND; Liu S; Lau WL; Khazaeli M; Nazertehrani S; Moore ME; Marco ML; Martin RJ; Adams SH
    Am J Physiol Renal Physiol; 2016 May; 310(9):F857-71. PubMed ID: 26841824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.
    Ramezani A; Massy ZA; Meijers B; Evenepoel P; Vanholder R; Raj DS
    Am J Kidney Dis; 2016 Mar; 67(3):483-98. PubMed ID: 26590448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.